autologous TRAC locus-inserted CD19-STAR-T
/ Chinese PLA General Hospital
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 06, 2023
TRAC Locus-inserted CD19-targeting STAR-T Cell Therapy in r/r B-NHL
(clinicaltrials.gov)
- P1/2 | N=38 | Recruiting | Sponsor: Chinese PLA General Hospital | Initiation date: Dec 2022 ➔ Jun 2023
Trial initiation date • Diffuse Large B Cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • Lymphoma • Mantle Cell Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • BCL2 • BCL6 • CCND1 • IL10 • IL2 • IL6 • TNFA
November 30, 2022
TRAC Locus-inserted CD19-targeting STAR-T Cell Therapy in r/r B-NHL
(clinicaltrials.gov)
- P1/2 | N=38 | Recruiting | Sponsor: Chinese PLA General Hospital
New P1/2 trial • Diffuse Large B Cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • Lymphoma • Mantle Cell Lymphoma • Non-Hodgkin’s Lymphoma • Oncology • BCL2 • BCL6 • CCND1 • CD19 • IL10 • IL2 • IL6 • TNFA
1 to 2
Of
2
Go to page
1